Dr. Karisa C. Schreck, MD

Dr. Schreck practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Schreck's NPI, 1871897934, was assigned on January 4, 2011. Dr. Schreck graduated from Johns Hopkins University School of Medicine in 2012. Dr. Schreck holds Maryland license D81331.

Dr. Schreck's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Schreck's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Schreck is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Schreck to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schreck practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Schreck's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Schreck is licensed in Maryland.

CMS data shows 58 Medicare services from Dr. Schreck across 2 procedure codes in 2024, all of them office visits, for 44 Medicare patients. Medicare paid $5,333 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Dr. Schreck in 2024. The largest group is 65 to 74, with 22 patients. 61% of them have high cholesterol, and 43% have high blood pressure. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schreck's median patient age at 64, with 56% women.

In 2024, Dr. Schreck wrote 198 Medicare Part D claims for 25 patients. 83% of them were for generic drugs. CMS names the drug for 79 of them, across 4 drugs with 11 or more claims each, at $2,129 in total drug cost. In 2023, CMS named 84 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Schreck for performance year 2024, reported as part of a group. CMS lists Dr. Schreck as offering telehealth.

Dmand AI links 44 papers to Dr. Schreck, published from 2011 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Brain Neoplasms, Glioma and Glioblastoma. Dr. Schreck has published most often in J Neurooncol. Dr. Schreck's most frequent co-authors are Chetan Bettegowda, MD, PhD, David Olayinka Kamson, MD, PhD and Debraj Mukherjee, MD.

Dmand AI links Dr. Schreck to 1 clinical trial. Conditions studied include Gliosarcoma and Glioblastoma.

CMS Open Payments shows 6 general payments to Dr. Schreck from 4 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 54% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,944.

Dr. Schreck graduated from Johns Hopkins University School of Medicine in 2012.